|
Exhibit 99.1
|
|
Company announcement dated May 14, 2025, “Nexxen Reports First Quarter 2025 Financial Results”.
|
| By: |
/S/ Sagi Niri
|
| Name: |
Sagi Niri
|
| Title: |
Chief Financial Officer
|
|
Exhibit List
|
||
| • |
Record Q1 Contribution ex-TAC of $75.0 million, up 8% year-over-year
|
| • |
Record Q1 programmatic revenue of $71.8 million, up 10% year-over-year
|
| • |
Record Q1 CTV revenue of $26.4 million, up 40% year-over-year
|
| • |
CTV revenue increased to 37% of programmatic revenue from 29% in Q1 2024
|
| • |
Programmatic revenue reflected 92% of revenue compared to 88% in Q1 2024
|
| • |
Adjusted EBITDA of $23.1 million, up 95% year-over-year, representing a 31% Adjusted EBITDA Margin on a Contribution ex-TAC basis (30% on a revenue basis), compared to 17% (16% on a revenue basis) in Q1 2024
|
| • |
Video revenue increased to 75% of programmatic revenue from 66% in Q1 2024
|
| • |
$164.7 million cash and cash equivalents as of March 31, 2025, alongside $90 million undrawn on the Company’s revolving credit facility and no long-term debt
|
| o |
Nexxen reaffirms its prior full year 2025 financial guidance:
|
| • |
Full year 2025 Contribution ex-TAC of approximately $380 million
|
| • |
Full year 2025 programmatic revenue to reflect approximately 90% of full year 2025 revenue
|
| • |
Full year 2025 Adjusted EBITDA of approximately $125 million
|
| o |
While the broader advertising market is experiencing softness in Q2 amid economic uncertainty and evolving U.S. trade policies, the Company remains confident in its full year 2025 guidance, contingent upon no significant deterioration in
macroeconomic or advertising conditions. This confidence is supported by strong, ongoing support from Nexxen’s clients and partners.
|
| o |
Though the Company remains confident in its full year 2025 guidance based on current visibility and spending trends observed to this point in Q2, it also acknowledges the dynamic nature of the advertising landscape and that additional
macroeconomic shocks, tariff impacts or policy shifts could materially affect market sentiment, consumer behavior and advertising demand.
|
| o |
Management expects to continue investments in technology, data and Generative AI throughout 2025 to advance the usability, interconnectivity and performance of Nexxen’s platform. These investments are expected to strengthen the Company’s
competitive advantages, drive greater wallet share from customers, attract new partners and accelerate Nexxen’s growth opportunity.
|
| • |
Streamlined to a single U.S. Ordinary Share listing on Nasdaq in February 2025, driving stronger investor and analyst interest, higher trading volume and eligibility for inclusion in select stock indices.
|
| • |
Added 101 new actively spending first-time advertiser customers in Q1 2025 across travel, government, financial services and other verticals, including 15 new enterprise self-service advertiser customers.
|
| • |
Onboarded 63 new supply partners across several verticals and formats in Q1 2025.
|
| • |
Enhanced Nexxen’s live sports advanced TV offerings through partnerships with FOX Sports, DirecTV, FanDuel Sports Network (formerly Bally Sports) and others, as well as programmatic advertising platform StackAdapt.
|
| • |
Expanded partnership with Tubi, one of the largest free ad-supported streaming services, beyond the U.S. to the U.K. to increase programmatic advertising revenue opportunities.
|
| • |
Launched Nexxen U, a first-of-its-kind educational program dedicated to the convergence of linear, CTV and digital media, with experts from Tinuiti, KINESSO and others teaching courses, and hundreds of learners already participating.
|
| o |
Nexxen repurchased 3,666,864 Ordinary Shares during Q1 2025 at an average price of $8.95, reflecting a total investment of $32.9 million.
|
| o |
The Company both completed its previous $50 million Ordinary Share repurchase program and launched a new and ongoing $50 million Ordinary Share repurchase program in April 2025, which is expected to continue until the earlier of November
19, 2025, or completion. The ongoing program does not obligate Nexxen to repurchase any particular amount of Ordinary Shares and the program may be suspended, modified or discontinued at any time at the Company’s discretion, subject to
applicable law.
|
| o |
From March 1, 2022, when the Company launched a series of share repurchase programs, through March 31, 2025, Nexxen repurchased 22,621,472 Ordinary Shares, or 29.2% of shares outstanding, reflecting a total investment of $190.2 million.
|
| o |
As of April 30, 2025, the Company had approximately $39.0 million remaining on its Ordinary Share repurchase program authorization.
|
| o |
Nexxen’s Board of Directors intends to continue to evaluate implementing additional share repurchase programs following completion of the ongoing program, subject to then current market conditions, necessary approvals and the Company’s
valuation.
|
| Three months ended March 31 | ||||||||||||
|
|
2025
|
2024
|
%
|
|||||||||
|
IFRS highlights
|
||||||||||||
|
Revenue
|
78.3
|
74.4
|
5
|
%
|
||||||||
|
Programmatic revenue
|
71.8
|
65.6
|
10
|
%
|
||||||||
|
Operating profit (loss)
|
3.4
|
(6.6
|
)
|
153
|
%
|
|||||||
|
Net income (loss) margin on a gross profit basis
|
3
|
%
|
(14
|
%)
|
||||||||
|
Total comprehensive income (loss)
|
2.4
|
(7.3
|
)
|
133
|
%
|
|||||||
|
Diluted earnings (loss) per share (*)
|
0.02
|
(0.10
|
)
|
126
|
%
|
|||||||
|
Non-IFRS highlights
|
||||||||||||
|
Contribution ex-TAC
|
75.0
|
69.7
|
8
|
%
|
||||||||
|
Adjusted EBITDA
|
23.1
|
11.9
|
95
|
%
|
||||||||
|
Adjusted EBITDA Margin on a Contribution ex-TAC basis
|
31
|
%
|
17
|
%
|
||||||||
|
Non-IFRS net income
|
10.6
|
1.2
|
808
|
%
|
||||||||
|
Non-IFRS diluted earnings per share (*)
|
0.16
|
0.02
|
898
|
%
|
||||||||
| • |
When: May 14, 2025, at 9:00 AM ET
|
| • |
Webcast: A live and archived webcast can be accessed from the Events and Presentations section of Nexxen’s Investor Relations website at https://investors.nexxen.com/
|
| • |
Participant Dial-In Numbers:
|
| o |
U.S. / Canada Toll-Free Dial-In Number: (888) 596-4144
|
| o |
U.K. Toll-Free Dial-In Number: +44 800 260 6470
|
| o |
International Dial-In Number: +1 (646) 968-2525
|
| o |
Conference ID: 8777366
|
| o |
Contribution ex-TAC: Contribution ex-TAC for Nexxen is defined as gross profit plus depreciation and amortization attributable to cost of revenue and cost of revenue (exclusive of depreciation and
amortization) minus the Performance media cost (“traffic acquisition costs” or “TAC”). Performance media cost represents the costs of purchases of impressions from publishers on a cost-per-thousand impression basis in our non-core Performance
activities. Contribution ex-TAC is a supplemental measure of our financial performance that is not required by or presented in accordance with IFRS. Contribution ex-TAC should not be considered as an alternative to gross profit as a measure
of financial performance. Contribution ex-TAC is a non-IFRS financial measure and should not be viewed in isolation. We believe Contribution ex-TAC is a useful measure in assessing the performance of Nexxen because it facilitates a consistent
comparison against our core business without considering the impact of traffic acquisition costs related to revenue reported on a gross basis.
|
| o |
Adjusted EBITDA: We define Adjusted EBITDA for Nexxen as total comprehensive income (loss) for the period adjusted for foreign currency translation differences for foreign operations, tax expenses
(benefit), financial income (expenses), net, depreciation and amortization, stock-based compensation expenses and delisting related one-time costs. Adjusted EBITDA is included in the press release because it is a key metric used by management
and our Board of Directors to assess our financial performance. Adjusted EBITDA is frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Management believes that Adjusted EBITDA is an
appropriate measure of operating performance because it eliminates the impact of expenses that do not relate directly to the performance of the underlying business.
|
| o |
Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA on a Contribution ex-TAC basis.
|
| o |
Non-IFRS Net Income and Non-IFRS Earnings per Share: We define non-IFRS earnings per share as non-IFRS net income divided by non-IFRS weighted-average shares outstanding. Non-IFRS net income is
equal to net income (loss) excluding amortization of acquired intangibles, delisting related one-time costs and stock-based compensation expenses, and also considers the tax effects of non-IFRS adjustments. In periods in which we have
non-IFRS net income, non-IFRS weighted-average shares outstanding used to calculate non-IFRS earnings per share includes the impact of potentially dilutive shares. Potentially dilutive shares consist of stock options, restricted stock
awards, restricted stock units and performance stock units, each computed using the treasury stock method. We believe non-IFRS earnings per share is useful to investors in evaluating our ongoing operational performance and our trends on a
per share basis and also facilitates comparison of our financial results on a per share basis with other companies, many of which present a similar non-IFRS measure. However, a potential limitation of our use of non-IFRS earnings per share
is that other companies may define non-IFRS earnings per share differently, which may make comparison difficult. This measure may also exclude expenses that may have a material impact on our reported financial results. Non-IFRS earnings per
share is a performance measure and should not be used as a measure of liquidity. Because of these limitations, we also consider the comparable IFRS measure of net income (loss).
|
|
|
Three months ended March 31
|
|||||||||||
|
|
2025
|
2024
|
%
|
|||||||||
|
($ in thousands)
|
||||||||||||
|
Total comprehensive income (loss)
|
2,391
|
(7,286
|
)
|
133
|
%
|
|||||||
|
Foreign currency translation differences for foreign operation
|
(758
|
)
|
412
|
|||||||||
|
Tax expenses (benefit)
|
2,876
|
(225
|
)
|
|||||||||
|
Financial income (expenses), net
|
(1,060
|
)
|
545
|
|||||||||
|
Depreciation and amortization
|
15,267
|
15,793
|
||||||||||
|
Stock-based compensation expenses
|
2,900
|
2,634
|
||||||||||
|
Delisting related one-time costs
|
1,520
|
-
|
||||||||||
|
Adjusted EBITDA
|
23,136
|
11,873
|
95
|
%
|
||||||||
|
|
Three months ended March 31
|
|||||||||||
|
|
2025
|
2024
|
%
|
|||||||||
|
($ in thousands)
|
||||||||||||
|
Revenue
|
78,330
|
74,432
|
5
|
%
|
||||||||
|
Cost of revenue (exclusive of depreciation and amortization)
|
(11,199
|
)
|
(14,538
|
)
|
||||||||
|
Depreciation and amortization attributable to cost of revenue
|
(12,294
|
)
|
(11,766
|
)
|
||||||||
|
Gross profit (IFRS)
|
54,837
|
48,128
|
14
|
%
|
||||||||
|
Depreciation and amortization attributable to cost of revenue
|
12,294
|
11,766
|
||||||||||
|
Cost of revenue (exclusive of depreciation and amortization)
|
11,199
|
14,538
|
||||||||||
|
Performance media cost
|
(3,342
|
)
|
(4,750
|
)
|
||||||||
|
Contribution ex-TAC (Non-IFRS)
|
74,988
|
69,682
|
8
|
%
|
||||||||
|
|
Three months ended March 31
|
|||||||||||
|
|
2025
|
2024
|
%
|
|||||||||
|
($ in thousands)
|
||||||||||||
|
Net income (loss)
|
1,633
|
(6,874
|
)
|
124
|
%
|
|||||||
|
Amortization of acquired intangibles
|
5,870
|
7,057
|
||||||||||
|
Delisting related one-time costs
|
1,520
|
-
|
||||||||||
|
Stock-based compensation expenses
|
2,900
|
2,634
|
||||||||||
|
Tax effect of Non-IFRS adjustments (1)
|
(1,284
|
)
|
(1,645
|
)
|
||||||||
|
Non-IFRS net income
|
10,639
|
1,172
|
808
|
%
|
||||||||
|
Weighted average shares outstanding—diluted (in millions) (2) (*)
|
65.7
|
72.2
|
||||||||||
|
Non-IFRS diluted earnings per share (in USD) (*)
|
0.16
|
0.02
|
898
|
%
|
||||||||
| (1) |
Non-IFRS net income includes the estimated tax impact from the expense items reconciling between net income (loss) and non-IFRS net income
|
| (2) |
Non-IFRS earnings per share is computed using the same weighted-average number of shares that are used to compute IFRS earnings (loss) per share
|
|
March 31
|
December 31
|
|||||||
|
2025
|
2024
|
|||||||
|
USD thousands
|
||||||||
|
Assets
|
||||||||
|
ASSETS:
|
||||||||
|
Cash and cash equivalents
|
164,712
|
187,068
|
||||||
|
Trade receivables, net
|
159,182
|
217,960
|
||||||
|
Other receivables
|
6,407
|
4,579
|
||||||
|
Current tax assets
|
3,987
|
3,373
|
||||||
|
TOTAL CURRENT ASSETS
|
334,288
|
412,980
|
||||||
|
Fixed assets, net
|
16,181
|
15,727
|
||||||
|
Right-of-use assets
|
28,790
|
31,500
|
||||||
|
Intangible assets, net
|
332,336
|
336,768
|
||||||
|
Deferred tax assets
|
14,474
|
17,800
|
||||||
|
Investment in shares
|
25,000
|
25,000
|
||||||
|
Other long-term assets
|
572
|
738
|
||||||
|
TOTAL NON-CURRENT ASSETS
|
417,353
|
427,533
|
||||||
|
TOTAL ASSETS
|
751,641
|
840,513
|
||||||
|
Liabilities and shareholders’ equity
|
||||||||
|
LIABILITIES:
|
||||||||
|
Current maturities of lease liabilities
|
14,191
|
14,340
|
||||||
|
Trade payables
|
173,049
|
228,514
|
||||||
|
Other payables
|
36,796
|
38,526
|
||||||
|
Current tax liabilities
|
4,247
|
4,677
|
||||||
|
TOTAL CURRENT LIABILITIES
|
228,283
|
286,057
|
||||||
|
Employee benefits
|
275
|
300
|
||||||
|
Long-term lease liabilities
|
19,854
|
22,857
|
||||||
|
Deferred tax liabilities
|
503
|
445
|
||||||
|
TOTAL NON-CURRENT LIABILITIES
|
20,632
|
23,602
|
||||||
|
TOTAL LIABILITIES
|
248,915
|
309,659
|
||||||
|
SHAREHOLDERS’ EQUITY:
|
||||||||
|
Share capital
|
360
|
377
|
||||||
|
Share premium
|
332,005
|
362,507
|
||||||
|
Other comprehensive loss
|
(1,718
|
)
|
(2,476
|
)
|
||||
|
Retained earnings
|
172,079
|
170,446
|
||||||
|
TOTAL SHAREHOLDERS’ EQUITY
|
502,726
|
530,854
|
||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
751,641
|
840,513
|
||||||
|
Three months ended March 31
|
||||||||
|
2025
|
2024
|
|||||||
|
USD thousands
|
||||||||
|
Revenue
|
78,330
|
74,432
|
||||||
|
Cost of Revenue (Exclusive of depreciation and amortization shown separately below)
|
11,199
|
14,538
|
||||||
|
Research and development expenses
|
12,764
|
12,381
|
||||||
|
Selling and marketing expenses
|
28,866
|
27,134
|
||||||
|
General and administrative expenses
|
6,785
|
11,140
|
||||||
|
Depreciation and amortization
|
15,267
|
15,793
|
||||||
|
Total operating costs
|
63,682
|
66,448
|
||||||
|
Operating Profit (loss)
|
3,449
|
(6,554
|
)
|
|||||
|
Financing income
|
(1,770
|
)
|
(2,425
|
)
|
||||
|
Financing expenses
|
710
|
2,970
|
||||||
|
Financing expenses (income), net
|
(1,060
|
)
|
545
|
|||||
|
Profit (loss) before taxes on income
|
4,509
|
(7,099
|
)
|
|||||
|
Tax expenses (benefits)
|
2,876
|
(225
|
)
|
|||||
|
Profit (loss) for the period
|
1,633
|
(6,874
|
)
|
|||||
|
Other comprehensive income (loss) items:
|
||||||||
|
Foreign currency translation differences for foreign operation
|
758
|
(412
|
)
|
|||||
|
Total other comprehensive income (loss) for the period
|
758
|
(412
|
)
|
|||||
|
Total comprehensive income (loss) for the period
|
2,391
|
(7,286
|
) |
|||||
|
Loss per share
|
||||||||
|
Basic earnings (loss) per share (in USD) (*)
|
0.03
|
(0.10
|
)
|
|||||
|
Diluted earnings (loss) per share (in USD) (*)
|
0.02
|
(0.10
|
)
|
|||||
|
Share capital
|
Share premium
|
Other comprehensive income (loss)
|
Retained earnings
|
Total
|
||||||||||||||||
|
USD thousands
|
||||||||||||||||||||
|
Balance as of January 1, 2025
|
377
|
362,507
|
(2,476
|
)
|
170,446
|
530,854
|
||||||||||||||
|
Total comprehensive income for the period
|
||||||||||||||||||||
|
Profit for the period
|
-
|
-
|
-
|
1,633
|
1,633
|
|||||||||||||||
|
Other comprehensive income:
|
||||||||||||||||||||
|
Foreign currency translation
|
-
|
-
|
758
|
-
|
758
|
|||||||||||||||
|
Total comprehensive income for the period
|
-
|
-
|
758
|
1,633
|
2,391
|
|||||||||||||||
|
Transactions with owners, recognized directly in equity
|
||||||||||||||||||||
|
Own shares acquired
|
(20
|
)
|
(32,864
|
)
|
-
|
-
|
(32,884
|
)
|
||||||||||||
|
Share based compensation
|
-
|
2,203
|
-
|
-
|
2,203
|
|||||||||||||||
|
Exercise of share options
|
3
|
159
|
-
|
-
|
162
|
|||||||||||||||
|
Balance as of March 31, 2025
|
360
|
332,005
|
(1,718
|
)
|
172,079
|
502,726
|
||||||||||||||
|
Balance as of January 1, 2024
|
417
|
410,563
|
(2,441
|
)
|
135,009
|
543,548
|
||||||||||||||
|
Total comprehensive loss for the period
|
||||||||||||||||||||
|
Loss for the period
|
-
|
-
|
-
|
(6,874
|
)
|
(6,874
|
)
|
|||||||||||||
|
Other comprehensive loss:
|
||||||||||||||||||||
|
Foreign currency translation
|
-
|
-
|
(412
|
)
|
-
|
(412
|
)
|
|||||||||||||
|
Total comprehensive loss for the period
|
-
|
-
|
(412
|
)
|
(6,874
|
)
|
(7,286
|
)
|
||||||||||||
|
Transactions with owners, recognized directly in equity
|
||||||||||||||||||||
|
Own shares acquired
|
(17
|
)
|
(16,075
|
)
|
-
|
-
|
(16,092
|
)
|
||||||||||||
|
Share based compensation
|
-
|
2,660
|
-
|
-
|
2,660
|
|||||||||||||||
|
Exercise of share options
|
2
|
189
|
-
|
-
|
191
|
|||||||||||||||
|
Balance as of March 31, 2024
|
402
|
397,337
|
(2,853
|
)
|
128,135
|
523,021
|
||||||||||||||
|
Three months ended
March 31
|
||||||||
|
2025
|
2024
|
|||||||
|
USD thousands
|
||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Profit (loss) for the period
|
1,633
|
(6,874
|
)
|
|||||
|
Adjustments for:
|
||||||||
|
Depreciation and amortization
|
15,267
|
15,793
|
||||||
|
Net financing expense (income)
|
(1,113
|
)
|
430
|
|||||
|
Gain on leases modification
|
(9
|
)
|
(4
|
)
|
||||
|
Share-based compensation and restricted shares
|
2,900
|
2,634
|
||||||
|
Tax expenses (benefits)
|
2,876
|
(225
|
)
|
|||||
|
Change in trade and other receivables
|
57,122
|
45,684
|
||||||
|
Change in trade and other payables
|
(58,640
|
)
|
(19,361
|
)
|
||||
|
Change in employee benefits
|
(23
|
)
|
(7
|
)
|
||||
|
Income taxes received
|
76
|
453
|
||||||
|
Income taxes paid
|
(1,552
|
)
|
(433
|
)
|
||||
|
Interest received
|
1,266
|
1,961
|
||||||
|
Interest paid
|
(528
|
)
|
(2,325
|
)
|
||||
|
Net cash provided by operating activities
|
19,275
|
37,726
|
||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
|
Change in pledged deposits, net
|
(58
|
)
|
(27
|
)
|
||||
|
Payments on finance lease receivable
|
390
|
443
|
||||||
|
Acquisition of fixed assets
|
(2,274
|
)
|
(2,719
|
)
|
||||
|
Acquisition and capitalization of intangible assets
|
(3,905
|
)
|
(3,618
|
)
|
||||
|
Repayment of debt investment
|
23
|
27
|
||||||
|
Net cash used in investing activities
|
(5,824
|
)
|
(5,894
|
)
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Acquisition of own shares
|
(31,979
|
)
|
(15,970
|
)
|
||||
|
Proceeds from exercise of share options
|
162
|
191
|
||||||
|
Leases repayment
|
(4,113
|
)
|
(4,027
|
)
|
||||
|
Net cash used in financing activities
|
(35,930
|
)
|
(19,806
|
)
|
||||
|
Net increase (decrease) in cash and cash equivalents
|
(22,479
|
)
|
12,026
|
|||||
|
CASH AND CASH EQUIVALENTS AS OF THE BEGINNING OF PERIOD
|
187,068
|
234,308
|
||||||
|
EFFECT OF EXCHANGE RATE FLUCTUATIONS ON CASH AND CASH EQUIVALENTS
|
123
|
(1,397
|
)
|
|||||
|
CASH AND CASH EQUIVALENTS AS OF THE END OF PERIOD
|
164,712
|
244,937
|
||||||